Paydirt
AC
Insider

Andrew Cheng

President and CEO

Andrew Cheng (President and CEO) filed 13 Form 4 reports in the past 24 months (0 purchases, 13 sales), most often in AKRO. The largest single filing was $2.0M of AKRO (37,837 sh across 3 lots, as filed), executed Jun 10 2025. Data as of Nov 8 2026.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
13
0 buys · 13 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$16.0M
shares × price, as filed
Last traded
Oct 10 2025
Filed Oct 14 2025
Open performance→
Volume by month
$2.4M$1.2M$0Dec 2024Jun 2025Dec 2025Jun 2026Dec 2024 · sells $1.0MJan 2025 · sells $1.6MFeb 2025 · sells $1.5MMar 2025 · sells $1.2MApr 2025 · sells $1.1MMay 2025 · sells $1.2MJun 2025 · sells $2.4MJul 2025 · sells $1.5MAug 2025 · sells $1.4MSep 2025 · sells $1.3MOct 2025 · sells $1.6M
Buys $0 Sells $16.0M

Shares × price, as filed · by filing month · past 24 months

Most traded names
AKRO AKRO 0 buys · 13 sells 13 filings
Recent filings
AKROSALE Akero Therapeutics, Inc. View filing → $1.2M
28,784 sh × $41.75
Exec Mar 10 2025
Filed Mar 12 2025 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. View filing → $1.5M
29,051 sh across 3 lots
Exec Feb 10 2025
Filed Feb 11 2025 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. View filing → $1.6M
30,000 sh across 3 lots
Exec Jan 27 2025
Filed Jan 29 2025 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. View filing → $242K
7,855 sh × $30.79
Exec Dec 10 2024
Filed Dec 12 2024 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. View filing → $802K
25,000 sh × $32.09
Exec Dec 2 2024
Filed Dec 4 2024 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. View filing → $3.4M
108,366 sh across 2 lots
Exec Nov 1 2024
Filed Nov 5 2024 · 5:30 PM ET